Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi-dose KwikPen, giving patients a simpler way to receive a full month ...
Investors have ignored healthcare as they’ve tried to capture earnings momentum in AI-related semiconductor stocks.
The $3.5 billion Lehigh Valley site will develop Lilly's next-generation weight-loss medicines, including retatrutide Company plans to create more than 2,800 manufacturing and construction jobs at ...
Lilly’s experimental drug met endpoints for blood-sugar level reduction and weight loss at trial.
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Nvidia Corp. is partnering with Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies announced the collaboration today. They plan to ...
KwikPen® for single-patient use available from Lilly at $449 across all doses through the Lilly Employer Connect platform, with reduced cost-share ...
Global pharmaceutical firm Eli Lilly and Co. will invest $3.5 billion to build a manufacturing plant in Upper Macungie Township that is expected to create 850 jobs. “This is the largest single project ...
INDIANAPOLIS (WISH) — Indianapolis-based pharmaceutical giant Eli Lilly and Co. has committed up to $40 million to Indiana University to expand access to clinical trials and innovative treatments for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Charlotte has long watched the ...
You don't have to go all in to profit from AI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results